Pfizer UK hints at disclosure of payments to doctors
January 19, 2009Medical Communications ethics
The UK might soon follow US companies by publicly declaring payments made to opinion leaders. David Gillen, Pfizer UK's medical …
Senior Creative Appointments at LEC
January 16, 2009Medical Communications
LANE EARL COX, one of the UK’s leading healthcare communications companies, is pleased to announce two senior appointments to its …
FDA moves to make imports safer
January 16, 2009Manufacturing and Production FDA, supply chain
The Food and Drug Administration is stepping up efforts to prevent counterfeit and contaminated medicines entering the US, and is …
Why do people refuse job offers?
January 15, 2009Business Services careers, recruitment
The consequences of a senior executive refusing a job offer at the final stage of the recruitment process can be …
Pfizer announces R&D job losses
January 15, 2009Research and Development Pfizer
Jobs losses at Pfizer's research and development centre in Sandwich, Kent look a certainty after the company announced cutbacks to …
Pfizer launches anti-counterfeiting cinema advert
January 15, 2009British cinemagoers are to be confronted with a hard-hitting advert warning them about the dangers of buying counterfeit medicines. Pfizer …
Doctors doubt benefits of OTC switches
January 15, 2009Sales and Marketing OTC
A survey of doctors has found many doubt that patients benefit from more prescription-only drugs being made available over-the-counter. Some …
PCTs will struggle with Next Stage reforms, say MPs
January 15, 2009Sales and Marketing NHS, hc, reform
Lord Darzi's forthcoming programme of NHS reforms will be hampered by PCT failings, according to MPs. The Health Select Committee …
Most GPs offering extended hours
January 15, 2009NHS, primary
More than two-thirds of GP surgeries are now offering extended opening hours, according to official figures. The Department of Health …
GSK opens US hub for vaccine manufacturing
January 14, 2009Manufacturing and Production GSK
GlaxoSmithKline has officially unveiled a $300 million manufacturing plant in Pennsylvania that will serve as the cornerstone of its US …
A postcard from … Spain
January 14, 2009Research and Development, Sales and Marketing Spain, healthcare, pharma
Wellcome Trust backs epigenetics project
January 13, 2009Research and Development epigenetics
A public-private partnership aiming to determine the three-dimensional structure of medically-relevant proteins and put them in the public domain has …
Getting up to speed with India
January 12, 2009Research and Development India, clinical trials, ethics
On a recent trip I made to India, the resourcefulness of the country's people was demonstrated to me as soon …
End of the line for European paracetamol
January 12, 2009Manufacturing and Production EU
The last European plant manufacturing paracetamol closed for the final time at the turn of the year, another sign that …
Actavis agrees deal with FDA on manufacturing problems
January 9, 2009Manufacturing and Production Actavis
Generic drug manufacturer Actavis will continue the lockdown of its New Jersey manufacturing facilities that breached quality standards, but hopes …
UK biotech forced to hang on for government aid
January 9, 2009Research and Development biotech
Cash-stricken UK biotech has been left hanging on for government funding, without any guarantee it will get the support needed. …
UK pharma to lose
January 8, 2009Sales and Marketing ABPI, NHS, par
The UK pharmaceutical industry stands to lose £225 million in annual profits under its new pricing agreement with the government. …
Lifeline for troubled LyondellBasell
January 8, 2009Manufacturing and Production Lyondell, excipients
LyondellBasell, the world’s third-largest petrochemical company and a supplier of a number of pharmaceutical raw materials, has filed for Chapter …
Novartis boosts vaccine pipeline
January 8, 2009Research and Development, Sales and Marketing Novartis, recruitment, vaccines
Novartis has added an investigational vaccine to its pipeline through a $20 million deal with AlphaVax. The North Carolina-based biotech …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
